India Diabetes Care Market, By Product Type (Diabetes Care Devices, Diabetes Care Drugs), By Diabetes Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospitals, Clinics), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

The India Diabetes Care Market was valued at USD 15.01 billion in 2024 and is expected to reach USD 21.56 billion by 2030, growing at a CAGR of 6.18% over the forecast period. The India Diabetes Care Market has undergone remarkable growth and transformation in recent years, propelled by the escalating prevalence of diabetes, heightened awareness of the condition, and technological advancements. The surge in diabetes cases impacting millions across the country is anticipated to increase further, particularly as lifestyle-related diseases become more widespread.

This market represents a significant opportunity for stakeholders, driven by the rising incidence of diabetes, ongoing innovations, and growing health awareness. However, to thrive in this dynamic landscape, companies must navigate several challenges, including cost considerations, accessibility of care, and regulatory complexities.

To effectively capture market share and enhance health outcomes for diabetes patients in India, strategic investments in research and development are paramount. Additionally, targeted marketing initiatives will be essential in addressing the diverse needs of consumers and healthcare providers alike. By focusing on these areas, companies can position themselves advantageously in this burgeoning market.

Key Market Drivers

Rising Prevalence of Diabetes

The rising prevalence of diabetes in India is a major force driving demand for diabetes care solutions, as a Lancet analysis cited by major Indian media reported that the country had 212 million adults living with diabetes in 2022, the highest in the world, with prevalence among women rising from 11.9 percent in 1990 to 23.7 percent in 2022 and among men from 11.3 percent to 21.4 percent over the same period.

This expanding disease burden is steadily increasing the need for routine glucose monitoring, insulin delivery, and long term therapy management, especially as a large share of patients still remain untreated and therefore need better access to diagnosis, adherence tools, and continuous care support. The market is also benefiting from more advanced diabetes technologies entering India, with Abbott stating that FreeStyle Libre is available in the country for adults, children above four years, and women with gestational diabetes, providing real time continuous glucose readings without fingersticks, while Medtronic says its MiniMed 640G linked CGM updates readings every five minutes and can predict low glucose events 30 minutes in advance.

For instance, Abbott said its FreeStyle Libre technology is already transforming diabetes management for over seven million people globally and has now been extended in India through the launch of the FreeStyle Libre 2 Plus sensor, showing how major companies are investing in smarter, more convenient diabetes care platforms as India’s patient burden continues to rise.

Technological Advancements in Diabetes Management

Technological advancements are playing a decisive role in expanding diabetes care adoption in India because they are shifting management from episodic fingerstick testing to connected, real time, and increasingly personalized monitoring and treatment ecosystems.

Continuous glucose monitoring is at the center of this shift, with Abbott stating that its FreeStyle Libre system in India provides real time continuous glucose readings for adults, children above four years, and women with gestational diabetes, while the India specific FreeStyle LibreLink app supports automatic glucose readings, alerts, trend review, note logging for food and insulin, and data sharing with doctors and family members.

Insulin delivery is also becoming smarter, as Medtronic says its MiniMed 780G system can automatically adjust basal insulin every five minutes based on CGM readings, and Novo Nordisk’s NovoPen 6 and NovoPen Echo Plus smart pens automatically record the time, date, and units of each dose while allowing insulin data to be viewed alongside glucose information in connected apps. These innovations are improving adherence, safety, and decision making for both patients and clinicians, while also fitting well with telemedicine and remote monitoring models that are increasingly relevant in India’s chronic care landscape.

For instance, Abbott says more than seven million people globally use its FreeStyle Libre technology and has extended this platform in India with the FreeStyle Libre 2 Plus sensor, showing how major companies are continuously investing in smarter digital diabetes tools that can strengthen long term care outcomes in the country.

Increase in the Aging Population

India’s rapidly aging population is becoming an important growth driver for diabetes care because the India Ageing Report 2023 states that the number of people aged 60 and above reached 149 million in 2022, or 10.5 percent of the population, and is projected to rise to 347 million, or 20.8 percent, by 2050.

This demographic shift matters directly for diabetes management since older adults are more vulnerable to metabolic disorders, and a national analysis of older Indians found diabetes prevalence of 12.4 percent overall, with rates of 19 percent in urban areas and 6 percent in rural areas, showing that the need for monitoring, medicines, and chronic care support extends well beyond major cities.

As age advances, providers must expand regular screening, nutrition counseling, and long term glycemic control services, while rural health systems also need stronger access to diagnostics and follow up because population aging is spreading across both developed and underserved regions.

For instance, Abbott’s FreeStyle Libre system is marketed in India for adults, children above four years, and women with gestational diabetes, and the company says its CGM technology provides a 24 by 7 glucose profile for up to 14 days, illustrating how major diabetes care companies are introducing senior friendly and data driven monitoring tools that can support more effective disease management as India’s elderly population grows.

Download Free Sample Report

Key Market Challenges

Cost and Affordability of Diabetes Care Solutions

One of the most pressing challenges is the cost associated with diabetes care solutions, including medications, monitoring devices, and healthcare services. Many patients in India face financial constraints that limit their access to necessary treatments and tools. Despite a growing middle class, a significant portion of the population still lives on low incomes, making it difficult for them to afford regular healthcare expenses.

This affordability issue is compounded by the lack of comprehensive insurance coverage for diabetes care. While some private insurance plans may cover basic diabetes management, many patients rely on out-of-pocket expenditures, which can be prohibitively expensive. Consequently, many individuals may delay seeking treatment or forgo purchasing essential monitoring devices and medications, leading to poorer health outcomes. This reluctance ultimately restricts market growth as the demand for diabetes care products remains unmet.

Limited Awareness and Education

Despite increasing awareness of diabetes, there remains a significant knowledge gap regarding its management among various demographics in India. Many patients lack a thorough understanding of the disease, its risks, and the importance of regular monitoring and lifestyle changes. In rural and semi-urban areas, this challenge is particularly pronounced, where access to education and healthcare resources is limited. An alarming 50% of India’s diabetes patients remain unaware of their condition until it significantly impacts their health and quality of life. The widespread adoption of sedentary lifestyles and poor dietary habits has contributed to this growing issue. Projections indicate that by 2045, India could be home to 124 million diabetes patients, underscoring the urgent need for enhanced awareness, early detection, and preventive healthcare measures to address this escalating public health crisis.

The lack of awareness not only affects patient engagement but also hinders the adoption of innovative diabetes management solutions, such as continuous glucose monitors and mobile health applications. Educational initiatives are often underfunded or poorly executed, resulting in insufficient outreach to those most at risk. To overcome this challenge, stakeholders must invest in comprehensive educational programs that empower patients with knowledge about diabetes management and the available care options.

Key Market Trends

Digital Health Solutions and Telemedicine

The rapid adoption of digital health solutions is transforming diabetes care in India. The integration of telemedicine and mobile health (mHealth) applications is enhancing patient access to healthcare services, particularly in rural and underserved areas. These technologies allow patients to consult healthcare professionals remotely, receive timely advice, and monitor their conditions without the need for frequent hospital visits.

Telemedicine platforms are increasingly being utilized for regular check-ups, medication adjustments, and education about diabetes management. mHealth applications facilitate self-monitoring of blood glucose levels, track dietary habits, and remind patients about medication schedules. The convenience and accessibility offered by these digital solutions are not only improving patient engagement and adherence but also driving demand for integrated diabetes care systems.

As more patients become accustomed to using technology for health management, the market for digital health solutions will continue to expand. Companies that develop user-friendly, culturally relevant applications and telehealth services will find significant opportunities for growth.

Personalized Medicine and Data Analytics

The trend towards personalized medicine is gaining traction in the diabetes care landscape in India. Advances in data analytics, artificial intelligence (AI), and machine learning are enabling healthcare providers to tailor treatment plans based on individual patient profiles. By analyzing data from continuous glucose monitors, wearable devices, and electronic health records, healthcare professionals can gain insights into each patient's unique metabolic responses and lifestyle factors.

This shift towards individualized care allows for more effective management strategies that can improve patient outcomes. For instance, AI-driven algorithms can recommend personalized insulin dosages or dietary modifications based on real-time data analysis. Additionally, these technologies can help predict potential complications and adjust treatment plans accordingly, enhancing the quality of care.

As healthcare providers increasingly adopt personalized approaches, the demand for advanced data analytics solutions will rise. Companies that invest in the development of AI-driven tools and platforms for diabetes management will be well-positioned to capture a growing market segment focused on personalized care.

Segmental Insights

Product Type Insights

Based on the category of product type, the Diabetes Care Device segment emerged as the dominant in the market for Diabetes Care in 2024. With the increasing incidence of diabetes, the demand for monitoring devices such as blood glucose meters, continuous glucose monitors (CGMs), and insulin delivery systems has surged. Patients require reliable tools for effective self-management of their condition, thereby driving growth in this segment. The introduction of advanced technologies, including smartphone integration, cloud-based data management, and user-friendly interfaces, has significantly enhanced the appeal of diabetes care devices. Innovations such as CGMs and insulin pens offer patients improved accuracy and ease of use, facilitating better glycemic control.

Enhanced awareness regarding the importance of regular monitoring and proactive diabetes management has led to increased adoption of diabetes care devices. Educational programs by healthcare providers and NGOs further empower patients to utilize these tools effectively. Various government initiatives aimed at promoting diabetes awareness and management have led to increased accessibility of diabetes care devices. Subsidies and partnerships with manufacturers have also made these devices more affordable for patients, particularly in rural areas.

The Indian market features a diverse range of diabetes care devices catering to different patient needs, from basic glucose meters to advanced CGMs. This diversity ensures that a broader segment of the population can access appropriate monitoring tools, enhancing the overall market potential. These factors collectively contribute to the growth of this segment.

Download Free Sample Report

Regional Insights

South India emerged as the dominant in the Diabetes Care market in 2024, holding the largest market share in terms of value. Southern India has a high prevalence of diabetes, driven by factors such as urbanization, lifestyle changes, and dietary habits that contribute to obesity and metabolic disorders. Cities like Chennai and Bengaluru report some of the highest rates of diabetes in the country.

The region boasts a well-developed healthcare infrastructure, including numerous specialty clinics, hospitals, and research institutions dedicated to diabetes care. The presence of institutions such as the Indian Institute of Diabetes in Chennai and the National Institute of Mental Health and Neurosciences in Bengaluru enhances the availability of specialized services. Higher levels of health awareness and education regarding diabetes management also play a crucial role. Public health initiatives and community outreach programs have successfully increased awareness about the importance of early diagnosis and lifestyle modifications.

Recent Developments

• In March 2025, Eli Lilly launched Mounjaro in India, bringing its blockbuster diabetes and weight-management therapy into one of the world’s largest metabolic disease markets ahead of rival Novo Nordisk’s comparable obesity push. Reuters described the launch as a significant entry into a country facing rising obesity and diabetes rates, making it one of the most important product rollouts in India’s diabetes-care space last year.
• In June 2025, Medtronic inaugurated a new Diabetes Global Capability Centre in Pune and said it would invest $50 million over five years to build out the site. The company said the centre would function as a diabetes-focused hub for customer care, advanced analytics, digital technology services, patient financial services, and operations, showing how diabetes care in India is increasingly being shaped by connected-service and data capabilities, not just medicines and devices alone.
• In August 2024- The All-India Institute of Medical Sciences (AIIMS) in Delhi has developed innovative software aimed at enhancing diabetes care in remote primary healthcare centers (PHCs). This software enables local healthcare professionals to input patient data, including risk factors such as blood pressure, cholesterol levels, and blood sugar readings. Upon processing this information, the software provides recommendations for appropriate treatments and medications. This advancement has the potential to significantly improve diagnosis and therapy by extending specialized diabetes care consultations to even the most isolated healthcare facilities.

Key Market Players

• Sanofi
• Novo Nordisk India Private Limited
• USV Private Limited
• Novartis AG
• Merck KGaA
• Becton Dickinson and Company
• F. Hoffmann-La Roche Ltd
• Health Arx Technologies Pvt. Ltd (BeatO)
• Sushant Kumar Ventures Pvt. Ltd. (Genefitletics-Your biology decoded)

Report Scope:

In this report, the India Diabetes Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Diabetes Care Market, By Product Type:

o   Diabetes Care Devices

o   Diabetes Care Drugs

• India Diabetes Care Market, By Diabetes Type:

o   Type 1 Diabetes

o   Type 2 Diabetes

o   Gestational Diabetes

• India Diabetes Care Market, By End User:

o   Home Care Settings

o   Hospitals

o   Clinics

• India Diabetes Care Market, By Region:

o   North India

o   South India

o   East India

o   West India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Diabetes Care Market.

Available Customizations:

 India Diabetes Care market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

 India Diabetes Care Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]